CFO4Life Group’s Innovator Defined Wealth Shield ETF BALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Sell
16,315
-3,791
-19% -$129K 0.08% 124
2026
Q1
$673K Sell
20,106
-12,305
-38% -$414K 0.1% 96
2025
Q4
$1.09M Buy
32,411
+9,250
+40% +$306K 0.15% 72
2025
Q3
$760K Buy
23,161
+12,305
+113% +$400K 0.11% 93
2025
Q2
$348K Sell
10,856
-23,836
-69% -$753K 0.05% 151
2025
Q1
$1.09M Buy
+34,692
New +$1.1M 0.18% 68

Other funds holding BALT

CFO4Life Group's BALT Position: Q2 2026 in Review

CFO4Life Group reduced its Innovator Defined Wealth Shield ETF (BALT) stake by 19% in Q2 2026, selling an estimated $129K and leaving 16,315 shares worth $559K. The position accounts for 0.08% of the portfolio, ranked #124.

CFO4Life Group first reported a position in BALT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.09M in Q1 2025. 297 funds tracked by Wall St. Rank hold BALT as of Q2 2026.

  • CFO4Life Group held 16,315 shares of Innovator Defined Wealth Shield ETF worth $559K as of Q2 2026.
  • CFO4Life Group sold 3,791 Innovator Defined Wealth Shield ETF shares in Q2 2026, an estimated $129K.
  • Innovator Defined Wealth Shield ETF made up 0.08% of CFO4Life Group's portfolio in Q2 2026, its #124 holding.
  • CFO4Life Group first reported a position in Innovator Defined Wealth Shield ETF in Q1 2025 and has held it in 6 quarters since.
  • CFO4Life Group's Innovator Defined Wealth Shield ETF position peaked at $1.09M in Q1 2025.
  • 297 funds tracked by Wall St. Rank held Innovator Defined Wealth Shield ETF as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.